DEA Asks FDA To Reconsider Rescheduling Marijuana From A Schedule 1 Drug


In another turn of events involving the declassification of marijuana, the DEA has recently asked the FDA to remove marijuana as a Schedule 1 drug. This is very imperative because earlier this year we brought you an article of Congress asking the President to reconsider rescheduling.  Though the verdict could take months to determine, this is a great sign for states who want to legalize marijuana; especially due to previous federal intervention cases of legalized states like Colorado and Washington.

[ The Street Excerpt]

–“This classification is, most reform advocates say, a major step forward to reform required at this juncture. It is, however, just the first step of many that still lie ahead for marijuana just on a legal and policy level to allow broader medical and continued encouragement for commercial development across the country.

“It is a good sign that the DEA is starting to walk back its policy of interfering with marijuana research and rescheduling,” said Morgan Fox of the Marijuana Policy Project, a drug reform focused group. “Unfortunately, this is a very tiny step.”

Just interdepartmental wrangling could take months, despite an abundance of readily available studies and other evidence. In addition, as many in the national medical movement know, Israel has led the world in cannabinoid research for close to the last decade . Such research is not possible in the U.S. now because of marijuana’s Schedule I classification.

That said, as marijuana is rapidly turning into the medical story of the year, it is doubtful that the issue will stall for long. Ultimately in a departmental overview such as this, which is highly politicized, impetus comes from the White House.

The issues at stake are as simple as they are ultimately complex — drug-based crime as it intersects with health care. These are the issues very much in the national spotlight this month in New York, Florida and Washington, D.C. (which falls under federal jurisdiction). Both state legislatures compromised their way to highly restrictive medical marijuana laws. In Florida, much wider use of medical marijuana is up for a landslide victory ballot vote in November . In D.C. the City Council unanimously decided to expand medical access and use.”—